MYOMO, INC.
About MYOMO, INC.
Myomo, Inc. is a wearable medical robotics company that develops and markets advanced myoelectric orthoses designed to improve arm and hand function for individuals with neuromuscular disorders and upper-limb paralysis. The company’s flagship MyoPro product line consists of powered upper-limb orthoses based on patented myoelectric technology. Headquartered in Cambridge, MA, Myomo was founded in 2004 and went public via a Regulation A+ offering, listing on the NYSE American under the ticker MYO.
- 🔗 Myomo - 2026 Company Profile, Funding, Competitors & Financials - Tracxn
- 🔗 Myomo Inc. Announces Proposed Regulation A+ Initial Public Offering and Plan to List on the NYSE MKT
- 🔗 NYSE American Section 610(b) Announcement | Myomo
- 🔗 MYO Stock Price, News & Analysis | Myomo
- 🔗 Myomo, Inc. (MYO) Balance Sheet - Yahoo Finance
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $17.2M over 12 rounds before becoming public via Regulation A+ IPO on NYSE American.
- Develops MyoPro myoelectric orthoses for patients with upper-limb paralysis and neuromuscular disorders.
- Reported 87 employees as of December 31, 2021 and revenue between $10M-$50M.
- Uses proceeds for sales/marketing expansion, product development, and working capital.
Ask StreetZero about MYOMO, INC.
Put our AI to work on this deal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account